Guy Meyer, M.D http://tadalafilo.org/tadalis%C2%AE-sx-un-tratamiento-recomendado-para-tratar-la-impotencia-sexual.html ., Eric Vicaut, M.D., Thierry Danays, M.D., Giancarlo Agnelli, M.D., Cecilia Becattini, M.D., Jan Beyer-Westendorf, M.D., Erich Bluhmki, M.D., Ph.D., Helene Bouvaist, M.D., Benjamin Brenner, M.D., Francis Couturaud, M.D., Ph.D., Claudia Dellas, M.D., Klaus Empen, M.D., Ana Franca, M.D.D., Annette Geibel, M.D., Samuel Z.
Two individuals with missing data concerning QRS pattern at enrollment were excluded from today’s study. Thus, the ultimate research sample included the 1818 patients from MADIT-CRT for whom baseline ECG data were available. The primary end point of the current study was death from any cause. Secondary end factors included a non-fatal heart-failing event and the combined end stage of a non-fatal heart-failure event or loss of life, whichever occurred first. Statistical Analysis All analyses in the present study were completed on an intention-to-treat basis .